<acronym id="i4o22"><center id="i4o22"></center></acronym>
<sup id="i4o22"><div id="i4o22"></div></sup>
<acronym id="i4o22"><center id="i4o22"></center></acronym>
  • 021-20985259

洛啟生物產品管線

Project Target Indicatioin Immunization Library Construction Functional identification Humanization Efficacy study Cell line Process Development GMP manufacturing TOX study IND
LQ001 CD47 Lymphoma,Non-Hodgkin;Ovarian Cancer
LQ002 PD-L1 Non-Small Cell Lung Cancer;Breast Cancer
LQ008 PD-1 Non-Small Cell Lung Cancer;Breast Cancer
LQ004 PD-L1/XX Head and Neck Squamous Cell Carcinoma
LQ005 PD-1/XX LarynxCancer;Head and Neck Squamous CellCarcinoma
LQ007 CD47/XX Lymphoma,Non-Hodgkin;Ovarian Cancer
上海洛啟生物醫藥技術有限公司版權所有Shanghai Novamab Biopharmaceuticals Co., Ltd   滬ICP備19011463號-1   滬公網安備 31011502016044號 技術支持:朗企科技
3分六合